Medical organizations including the CDC and American Academy of Pediatrics have not identified contraindications between GLP-1 agonists and routine immunizations
They both have the same active ingredient-exenatide-and are most effective when used in collaboration with proper diet and exercise

Some experimental models may observe: Temporary increases in fatigue-related observations following intense activity Variability in endurance-related response patterns Temporary muscular recovery-related discomfort Adaptation-related physiological variability Injection & Handling Considerations Improper storage, reconstitution, or administration techniques may increase the likelihood of: Administration-site irritation Local inflammation Reduced peptide stability or integrity Additional Research Notes Higher research amounts do not necessarily produce proportionally greater observations and may increase the likelihood of side-effectrelated observations Individual responses may vary depending on metabolic status, sleep quality, nutrition, exercise intensity, stress levels, and concurrent metabolic or mitochondrial-support compounds Combination protocols involving NAD, 5-Amino-1MQ, Semax, Selank, or other metabolic-regulation compounds may influence overall mitochondrial and physiological response patterns For Research Use Only Not intended to diagnose, treat, cure, or prevent any disease

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinsons disease: a randomised, double-blind, placebo-controlled trial
What happens if you take overdose of Lacarnit Injection